As 2013 winds down, Techonomy takes a moment to look back on highlights from the year, especially those that portend—we think—the future. Our Top Ten list recognizes the people, companies, and ideas that embodied how...
Medical researchers, genomics experts, and industry pundits took wildly divergent points of view in a media storm that erupted last week over FDA’s stern letter ordering 23andMe to stop marketing its Personal Genome Service. The...
Citing concerns "about the public health consequences of inaccurate results" from its Personal Genome Service, the FDA on Friday told 23andMe CEO Ann Wojcicki in a stern Warning Letter that her company must "immediately discontinue...
Could consumers be persuaded to snatch up DNA sequences as must-have accessories? With former Gilt Groupe President Andy Page in a new leadership role, 23andMe might be able to swing that. The personal genetics company...
With the holidays drawing near, we thought it was the perfect time to look at the top items on any Techonomic wishlist—gifts that make the most of advances in science and technology to help build...
One of the biggest hopes when the $3 billion Human Genome Project launched two decades ago was that it would one day put lots of basic genetic information into the hands of the general public....
If you've had your genome sequenced, there will soon be apps for that. Personal genome sequencing company 23andMe this week opened up its application program interface to allow third-party developers to build "a broad range...
